Christene Huang
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Swine | 40 | 2022 | 786 | 2.260 |
Why?
| Diphtheria Toxin | 13 | 2020 | 65 | 2.120 |
Why?
| Immunotoxins | 12 | 2022 | 35 | 2.000 |
Why?
| Swine, Miniature | 24 | 2016 | 73 | 1.820 |
Why?
| Transplantation Conditioning | 9 | 2016 | 159 | 1.290 |
Why?
| Transplantation Chimera | 11 | 2016 | 51 | 1.230 |
Why?
| Galectin 3 | 3 | 2022 | 21 | 1.220 |
Why?
| Lymphocyte Depletion | 9 | 2016 | 123 | 1.210 |
Why?
| Blood Component Removal | 2 | 2018 | 35 | 1.140 |
Why?
| Hematopoietic Stem Cell Transplantation | 11 | 2016 | 552 | 1.090 |
Why?
| CD3 Complex | 5 | 2013 | 94 | 1.040 |
Why?
| Graft vs Host Disease | 6 | 2016 | 224 | 0.880 |
Why?
| Swine Diseases | 5 | 2015 | 9 | 0.830 |
Why?
| Recombinant Fusion Proteins | 10 | 2020 | 658 | 0.800 |
Why?
| Skin Transplantation | 5 | 2016 | 60 | 0.730 |
Why?
| Lymphoproliferative Disorders | 5 | 2015 | 46 | 0.700 |
Why?
| Graft Rejection | 9 | 2016 | 555 | 0.700 |
Why?
| Bone Marrow Transplantation | 7 | 2015 | 260 | 0.670 |
Why?
| Isoantibodies | 5 | 2016 | 63 | 0.660 |
Why?
| Histocompatibility Antigens | 3 | 2015 | 102 | 0.630 |
Why?
| Animals | 58 | 2023 | 34345 | 0.600 |
Why?
| Cell Transplantation | 2 | 2010 | 39 | 0.600 |
Why?
| Interleukin-2 | 5 | 2020 | 424 | 0.600 |
Why?
| Transplantation, Homologous | 8 | 2016 | 434 | 0.590 |
Why?
| T-Lymphocytes, Regulatory | 6 | 2022 | 364 | 0.570 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 200 | 0.570 |
Why?
| Transplantation, Haploidentical | 1 | 2016 | 7 | 0.550 |
Why?
| Immunity, Humoral | 3 | 2015 | 116 | 0.550 |
Why?
| Lymphocyte Transfusion | 1 | 2016 | 19 | 0.550 |
Why?
| Blood Donors | 1 | 2016 | 109 | 0.500 |
Why?
| Receptors, CCR4 | 5 | 2020 | 16 | 0.490 |
Why?
| Graft Survival | 8 | 2015 | 510 | 0.480 |
Why?
| Transplantation Immunology | 4 | 2012 | 32 | 0.480 |
Why?
| Transplantation Tolerance | 5 | 2014 | 32 | 0.480 |
Why?
| T-Lymphocytes | 7 | 2015 | 1793 | 0.480 |
Why?
| Autoimmunity | 2 | 2022 | 835 | 0.470 |
Why?
| Cell Lineage | 2 | 2006 | 322 | 0.450 |
Why?
| Pichia | 8 | 2017 | 20 | 0.440 |
Why?
| Immunity, Cellular | 3 | 2013 | 277 | 0.430 |
Why?
| Cyclosporine | 7 | 2016 | 174 | 0.420 |
Why?
| Interleukin-2 Receptor alpha Subunit | 5 | 2020 | 70 | 0.420 |
Why?
| Tissue Engineering | 1 | 2016 | 379 | 0.410 |
Why?
| Inbreeding | 2 | 2009 | 17 | 0.380 |
Why?
| Antibodies | 2 | 2012 | 396 | 0.360 |
Why?
| Inflammation | 4 | 2022 | 2612 | 0.360 |
Why?
| Transplantation, Heterologous | 4 | 2021 | 197 | 0.360 |
Why?
| Whole-Body Irradiation | 4 | 2016 | 73 | 0.360 |
Why?
| Hematopoietic Stem Cells | 4 | 2013 | 366 | 0.350 |
Why?
| Immune Tolerance | 5 | 2015 | 338 | 0.350 |
Why?
| Umbilical Cord | 1 | 2010 | 82 | 0.350 |
Why?
| Transplantation | 2 | 2012 | 26 | 0.340 |
Why?
| Flow Cytometry | 11 | 2020 | 1108 | 0.330 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2009 | 93 | 0.330 |
Why?
| Lymphoma, T-Cell, Cutaneous | 2 | 2020 | 41 | 0.310 |
Why?
| Liver Diseases | 2 | 2022 | 325 | 0.310 |
Why?
| CTLA-4 Antigen | 3 | 2013 | 87 | 0.310 |
Why?
| Thymus Gland | 4 | 2015 | 301 | 0.280 |
Why?
| Cord Blood Stem Cell Transplantation | 1 | 2007 | 96 | 0.270 |
Why?
| Immunosuppressive Agents | 5 | 2015 | 693 | 0.270 |
Why?
| Chimerism | 1 | 2006 | 28 | 0.270 |
Why?
| Bone Marrow | 2 | 2010 | 259 | 0.270 |
Why?
| Hematologic Neoplasms | 1 | 2007 | 138 | 0.260 |
Why?
| Fetal Blood | 1 | 2007 | 278 | 0.260 |
Why?
| Galectins | 2 | 2022 | 23 | 0.250 |
Why?
| Recombinant Proteins | 7 | 2020 | 1327 | 0.250 |
Why?
| Cell Line, Tumor | 4 | 2017 | 2913 | 0.230 |
Why?
| Papio | 3 | 2015 | 99 | 0.230 |
Why?
| Antibodies, Monoclonal | 4 | 2017 | 1300 | 0.230 |
Why?
| Fiber Optic Technology | 1 | 2023 | 22 | 0.220 |
Why?
| Porphyrins | 1 | 2023 | 18 | 0.220 |
Why?
| Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 20 | 0.220 |
Why?
| Histocompatibility Antigens Class I | 3 | 2012 | 176 | 0.220 |
Why?
| Skin | 3 | 2018 | 698 | 0.220 |
Why?
| Histocompatibility Antigens Class II | 3 | 2012 | 356 | 0.220 |
Why?
| Antibody Specificity | 2 | 2017 | 191 | 0.210 |
Why?
| Histocompatibility Testing | 4 | 2015 | 125 | 0.210 |
Why?
| Hepatitis, Alcoholic | 1 | 2022 | 13 | 0.200 |
Why?
| Herpesviridae | 1 | 2022 | 21 | 0.200 |
Why?
| Muscle Stretching Exercises | 1 | 2022 | 17 | 0.200 |
Why?
| Yoga | 1 | 2022 | 30 | 0.200 |
Why?
| Meditation | 1 | 2022 | 38 | 0.200 |
Why?
| Major Histocompatibility Complex | 4 | 2005 | 223 | 0.190 |
Why?
| Epstein-Barr Virus Infections | 1 | 2022 | 73 | 0.190 |
Why?
| Leukapheresis | 3 | 2013 | 28 | 0.190 |
Why?
| Histocompatibility | 3 | 2015 | 28 | 0.190 |
Why?
| Immunoglobulin G | 2 | 2017 | 808 | 0.190 |
Why?
| Mice, SCID | 5 | 2017 | 337 | 0.190 |
Why?
| Endogenous Retroviruses | 1 | 2021 | 19 | 0.180 |
Why?
| Skin Neoplasms | 2 | 2020 | 852 | 0.180 |
Why?
| Spleen | 3 | 2007 | 513 | 0.180 |
Why?
| Mice, Inbred NOD | 5 | 2017 | 582 | 0.170 |
Why?
| Colony-Forming Units Assay | 5 | 2006 | 94 | 0.170 |
Why?
| Lymphoma | 1 | 2021 | 185 | 0.170 |
Why?
| Amino Acid Sequence | 6 | 2015 | 2098 | 0.170 |
Why?
| Postoperative Complications | 3 | 2022 | 2325 | 0.170 |
Why?
| Disease Models, Animal | 7 | 2015 | 3823 | 0.160 |
Why?
| Hematologic Diseases | 2 | 2012 | 61 | 0.160 |
Why?
| Base Sequence | 6 | 2015 | 2207 | 0.160 |
Why?
| B7-1 Antigen | 3 | 2013 | 70 | 0.160 |
Why?
| Molecular Sequence Data | 6 | 2015 | 2926 | 0.160 |
Why?
| Time Factors | 7 | 2017 | 6780 | 0.160 |
Why?
| Kidney Transplantation | 4 | 2005 | 593 | 0.160 |
Why?
| Interleukin-3 | 2 | 2011 | 27 | 0.160 |
Why?
| Freund's Adjuvant | 1 | 2018 | 17 | 0.150 |
Why?
| Lymphocyte Culture Test, Mixed | 4 | 2014 | 46 | 0.150 |
Why?
| Antibodies, Heterophile | 2 | 2015 | 13 | 0.150 |
Why?
| Betacoronavirus | 1 | 2020 | 263 | 0.140 |
Why?
| Papio hamadryas | 2 | 2013 | 5 | 0.140 |
Why?
| Haplotypes | 2 | 2012 | 496 | 0.140 |
Why?
| Antibody Affinity | 1 | 2017 | 56 | 0.140 |
Why?
| Antigens, CD19 | 1 | 2017 | 97 | 0.140 |
Why?
| Heterografts | 2 | 2013 | 131 | 0.130 |
Why?
| Antigen-Presenting Cells | 1 | 2016 | 157 | 0.130 |
Why?
| Immunoconjugates | 1 | 2017 | 90 | 0.130 |
Why?
| B-Lymphocytes | 2 | 2015 | 781 | 0.130 |
Why?
| Antigens, Heterophile | 1 | 2015 | 5 | 0.130 |
Why?
| Humans | 26 | 2022 | 125131 | 0.130 |
Why?
| Lymphatic Irradiation | 1 | 2015 | 10 | 0.130 |
Why?
| Polymerase Chain Reaction | 4 | 2012 | 1042 | 0.130 |
Why?
| Gene Expression | 5 | 2012 | 1528 | 0.130 |
Why?
| Lymphoma, B-Cell | 2 | 2013 | 87 | 0.130 |
Why?
| Pneumonia, Viral | 1 | 2020 | 360 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 347 | 0.120 |
Why?
| Composite Tissue Allografts | 1 | 2014 | 8 | 0.120 |
Why?
| Galactosyltransferases | 2 | 2013 | 13 | 0.120 |
Why?
| Hematopoietic Stem Cell Mobilization | 2 | 2012 | 21 | 0.120 |
Why?
| Lymphocyte Count | 2 | 2022 | 140 | 0.120 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 837 | 0.120 |
Why?
| Protein Biosynthesis | 2 | 2013 | 416 | 0.120 |
Why?
| L-Lactate Dehydrogenase | 2 | 2015 | 118 | 0.120 |
Why?
| Liver Transplantation | 1 | 2022 | 946 | 0.120 |
Why?
| Pregnancy, Animal | 1 | 2014 | 58 | 0.120 |
Why?
| Retinal Degeneration | 1 | 2014 | 28 | 0.110 |
Why?
| Leukocytes | 1 | 2015 | 292 | 0.110 |
Why?
| Plasmids | 2 | 2011 | 361 | 0.110 |
Why?
| Antilymphocyte Serum | 1 | 2013 | 66 | 0.110 |
Why?
| Mice | 10 | 2022 | 15984 | 0.110 |
Why?
| Cell- and Tissue-Based Therapy | 1 | 2014 | 55 | 0.110 |
Why?
| Lung Transplantation | 1 | 2015 | 273 | 0.110 |
Why?
| Stem Cell Transplantation | 1 | 2014 | 155 | 0.110 |
Why?
| Somatosensory Disorders | 1 | 2012 | 1 | 0.110 |
Why?
| Animals, Laboratory | 1 | 2012 | 13 | 0.100 |
Why?
| Macaca mulatta | 1 | 2013 | 149 | 0.100 |
Why?
| DNA Primers | 2 | 2012 | 545 | 0.100 |
Why?
| Macaca | 1 | 2012 | 56 | 0.100 |
Why?
| Glycosylation | 4 | 2013 | 133 | 0.100 |
Why?
| Immunotherapy | 2 | 2013 | 499 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1434 | 0.100 |
Why?
| Escherichia coli Infections | 1 | 2012 | 110 | 0.100 |
Why?
| Neoplasm Transplantation | 2 | 2013 | 250 | 0.100 |
Why?
| Edema | 1 | 2012 | 131 | 0.100 |
Why?
| Platelet Count | 2 | 2013 | 89 | 0.090 |
Why?
| Protein Binding | 5 | 2014 | 2014 | 0.090 |
Why?
| Treatment Outcome | 3 | 2018 | 9790 | 0.090 |
Why?
| CD40 Ligand | 1 | 2010 | 47 | 0.090 |
Why?
| Organ Transplantation | 1 | 2013 | 170 | 0.090 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2020 | 745 | 0.090 |
Why?
| Antigens, CD | 2 | 2003 | 466 | 0.090 |
Why?
| Injections, Subcutaneous | 1 | 2010 | 139 | 0.090 |
Why?
| Prednisolone | 1 | 2010 | 76 | 0.090 |
Why?
| Lymphocytes | 2 | 2021 | 356 | 0.090 |
Why?
| Rats | 2 | 2017 | 5517 | 0.090 |
Why?
| Blood Proteins | 2 | 2022 | 253 | 0.090 |
Why?
| Leukocytosis | 1 | 2009 | 36 | 0.090 |
Why?
| Sus scrofa | 2 | 2012 | 57 | 0.090 |
Why?
| Immunization | 1 | 2012 | 420 | 0.090 |
Why?
| Immunophenotyping | 2 | 2007 | 286 | 0.090 |
Why?
| Leukocyte Count | 2 | 2012 | 315 | 0.080 |
Why?
| Pluripotent Stem Cells | 2 | 2014 | 65 | 0.080 |
Why?
| Autoimmune Diseases | 1 | 2012 | 406 | 0.080 |
Why?
| Bone Marrow Cells | 3 | 2006 | 276 | 0.080 |
Why?
| Antigens | 1 | 2010 | 324 | 0.080 |
Why?
| Drug Administration Schedule | 1 | 2010 | 760 | 0.080 |
Why?
| Anemia | 1 | 2009 | 162 | 0.080 |
Why?
| Prognosis | 3 | 2022 | 3616 | 0.070 |
Why?
| Macaca fascicularis | 2 | 2018 | 54 | 0.070 |
Why?
| Varicellovirus | 1 | 2007 | 28 | 0.070 |
Why?
| Granulocyte Precursor Cells | 1 | 2006 | 7 | 0.070 |
Why?
| Neoplasms, Experimental | 1 | 2007 | 161 | 0.070 |
Why?
| Haploidy | 1 | 2006 | 22 | 0.070 |
Why?
| Cell Line | 3 | 2021 | 2806 | 0.070 |
Why?
| Models, Molecular | 1 | 2011 | 1450 | 0.070 |
Why?
| Antineoplastic Agents | 1 | 2017 | 2009 | 0.070 |
Why?
| Glucocorticoids | 1 | 2010 | 554 | 0.070 |
Why?
| Species Specificity | 3 | 2015 | 592 | 0.060 |
Why?
| Cross Reactions | 2 | 2016 | 117 | 0.060 |
Why?
| Female | 8 | 2022 | 64889 | 0.060 |
Why?
| Tissue Donors | 2 | 2005 | 352 | 0.060 |
Why?
| Pregnancy | 4 | 2015 | 5922 | 0.060 |
Why?
| Blood Group Incompatibility | 1 | 2004 | 15 | 0.060 |
Why?
| Allografts | 2 | 2015 | 137 | 0.060 |
Why?
| Models, Animal | 3 | 2015 | 373 | 0.060 |
Why?
| Erythroid Precursor Cells | 1 | 2003 | 4 | 0.060 |
Why?
| Blotting, Southern | 1 | 2003 | 71 | 0.060 |
Why?
| Stem Cell Factor | 1 | 2003 | 15 | 0.060 |
Why?
| Fetal Diseases | 1 | 2005 | 152 | 0.060 |
Why?
| Uterus | 1 | 2005 | 197 | 0.060 |
Why?
| Myeloid Progenitor Cells | 1 | 2003 | 16 | 0.060 |
Why?
| Multipotent Stem Cells | 1 | 2003 | 18 | 0.060 |
Why?
| Granulocytes | 1 | 2003 | 81 | 0.060 |
Why?
| Prenatal Diagnosis | 1 | 2005 | 173 | 0.050 |
Why?
| Hindlimb | 1 | 2004 | 137 | 0.050 |
Why?
| Blood Gas Analysis | 1 | 2023 | 86 | 0.050 |
Why?
| Biomarkers | 3 | 2022 | 3736 | 0.050 |
Why?
| Blood Physiological Phenomena | 1 | 2002 | 15 | 0.050 |
Why?
| Oximetry | 1 | 2023 | 98 | 0.050 |
Why?
| Binding, Competitive | 2 | 2014 | 209 | 0.050 |
Why?
| Cell Proliferation | 3 | 2015 | 2333 | 0.050 |
Why?
| Neoplasms | 1 | 2017 | 2340 | 0.050 |
Why?
| Dose-Response Relationship, Drug | 2 | 2017 | 2026 | 0.050 |
Why?
| Lung | 1 | 2015 | 3865 | 0.050 |
Why?
| Gestational Age | 1 | 2005 | 797 | 0.050 |
Why?
| Cells, Cultured | 2 | 2007 | 4159 | 0.050 |
Why?
| Patient Acuity | 1 | 2022 | 44 | 0.050 |
Why?
| Gammaherpesvirinae | 1 | 2002 | 39 | 0.050 |
Why?
| Gene Knockout Techniques | 2 | 2013 | 110 | 0.050 |
Why?
| Neutrophil Infiltration | 1 | 2022 | 100 | 0.050 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 83 | 0.050 |
Why?
| Herpesvirus 4, Human | 1 | 2022 | 129 | 0.050 |
Why?
| Solubility | 2 | 2012 | 241 | 0.050 |
Why?
| Fetus | 1 | 2005 | 713 | 0.050 |
Why?
| Protein Multimerization | 2 | 2014 | 163 | 0.050 |
Why?
| Cell Separation | 1 | 2002 | 299 | 0.050 |
Why?
| Genome, Viral | 1 | 2002 | 124 | 0.050 |
Why?
| Male | 7 | 2022 | 60792 | 0.050 |
Why?
| Rabbits | 2 | 2013 | 795 | 0.050 |
Why?
| Leukocytes, Mononuclear | 2 | 2014 | 517 | 0.050 |
Why?
| Monocytes | 1 | 2003 | 523 | 0.040 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2022 | 207 | 0.040 |
Why?
| Liver Cirrhosis | 1 | 2022 | 249 | 0.040 |
Why?
| T-Lymphocyte Subsets | 1 | 2022 | 406 | 0.040 |
Why?
| Cytokines | 2 | 2022 | 1927 | 0.040 |
Why?
| Inhibitory Concentration 50 | 1 | 2020 | 82 | 0.040 |
Why?
| Viral Proteins | 1 | 2022 | 302 | 0.040 |
Why?
| Membrane Glycoproteins | 1 | 2002 | 454 | 0.040 |
Why?
| Protein Processing, Post-Translational | 2 | 2013 | 420 | 0.040 |
Why?
| DNA | 2 | 2017 | 1406 | 0.040 |
Why?
| Risk | 1 | 2022 | 896 | 0.040 |
Why?
| Mice, Knockout | 2 | 2017 | 2736 | 0.040 |
Why?
| Oxygen | 1 | 2023 | 912 | 0.040 |
Why?
| Inflammation Mediators | 1 | 2022 | 515 | 0.040 |
Why?
| Safety-Based Drug Withdrawals | 1 | 2017 | 3 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2022 | 1992 | 0.030 |
Why?
| Tumor Burden | 1 | 2017 | 279 | 0.030 |
Why?
| Herpesvirus 1, Suid | 1 | 2015 | 1 | 0.030 |
Why?
| Tumor Virus Infections | 1 | 2015 | 41 | 0.030 |
Why?
| Calcineurin Inhibitors | 1 | 2015 | 61 | 0.030 |
Why?
| Tumor Cells, Cultured | 1 | 2017 | 902 | 0.030 |
Why?
| National Eye Institute (U.S.) | 1 | 2014 | 6 | 0.030 |
Why?
| Cell Engineering | 1 | 2014 | 6 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2022 | 2848 | 0.030 |
Why?
| Regenerative Medicine | 1 | 2014 | 46 | 0.030 |
Why?
| Cell Survival | 1 | 2017 | 1081 | 0.030 |
Why?
| Random Allocation | 1 | 2014 | 377 | 0.030 |
Why?
| Embryonic Stem Cells | 1 | 2014 | 111 | 0.030 |
Why?
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 15 | 0.030 |
Why?
| Blood Cell Count | 1 | 2013 | 57 | 0.030 |
Why?
| Animals, Genetically Modified | 1 | 2013 | 224 | 0.030 |
Why?
| Antigens, CD34 | 1 | 2013 | 98 | 0.030 |
Why?
| Hematocrit | 1 | 2013 | 97 | 0.030 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2013 | 139 | 0.030 |
Why?
| Congresses as Topic | 1 | 2014 | 215 | 0.030 |
Why?
| Epitope Mapping | 1 | 2012 | 51 | 0.030 |
Why?
| Drug Design | 1 | 2013 | 162 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 2013 | 369 | 0.030 |
Why?
| Lymph Nodes | 2 | 2005 | 467 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2014 | 419 | 0.020 |
Why?
| Blotting, Western | 1 | 2014 | 1233 | 0.020 |
Why?
| Risk Factors | 1 | 2004 | 9549 | 0.020 |
Why?
| Prospective Studies | 1 | 2022 | 6818 | 0.020 |
Why?
| Glycoproteins | 1 | 2012 | 330 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 1885 | 0.020 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2015 | 484 | 0.020 |
Why?
| Clinical Trials as Topic | 1 | 2014 | 1006 | 0.020 |
Why?
| Transcription, Genetic | 2 | 2007 | 1376 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 959 | 0.020 |
Why?
| Proto-Oncogene Proteins c-kit | 1 | 2006 | 61 | 0.020 |
Why?
| Open Reading Frames | 1 | 2007 | 125 | 0.020 |
Why?
| Conserved Sequence | 1 | 2007 | 222 | 0.020 |
Why?
| Splenectomy | 1 | 2005 | 58 | 0.020 |
Why?
| Middle Aged | 2 | 2022 | 29112 | 0.020 |
Why?
| Retrospective Studies | 1 | 2022 | 13708 | 0.020 |
Why?
| Risk Assessment | 1 | 2014 | 3274 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2014 | 5102 | 0.020 |
Why?
| Adult | 2 | 2022 | 33167 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2005 | 1144 | 0.010 |
Why?
| Monitoring, Physiologic | 1 | 2005 | 290 | 0.010 |
Why?
| Aged | 1 | 2022 | 20859 | 0.010 |
Why?
| RNA, Viral | 1 | 2007 | 587 | 0.010 |
Why?
| Creatinine | 1 | 2005 | 507 | 0.010 |
Why?
| Blood Transfusion | 1 | 2005 | 312 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 2012 | 1559 | 0.010 |
Why?
| Hybridomas | 1 | 2002 | 233 | 0.010 |
Why?
| Genes, Viral | 1 | 2002 | 93 | 0.010 |
Why?
| Sequence Alignment | 1 | 2002 | 338 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 2002 | 379 | 0.010 |
Why?
| Benzimidazoles | 1 | 2002 | 142 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2002 | 566 | 0.010 |
Why?
| Bone and Bones | 1 | 2004 | 300 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2002 | 319 | 0.010 |
Why?
| Mammals | 1 | 2002 | 260 | 0.010 |
Why?
| Transfection | 1 | 2002 | 923 | 0.010 |
Why?
| RNA, Messenger | 1 | 2007 | 2753 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2002 | 767 | 0.010 |
Why?
| Kidney | 1 | 2005 | 1379 | 0.010 |
Why?
| Phylogeny | 1 | 2002 | 823 | 0.010 |
Why?
| Incidence | 1 | 2004 | 2578 | 0.010 |
Why?
| United States | 1 | 2014 | 13613 | 0.010 |
Why?
|
|
Huang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) Derived automatically from this person's publications. _
Co-Authors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People in Profiles who have published with this person. _
Similar People ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors ![Expand Description](https://profiles.ucdenver.edu/Framework/Images/info.png) People whose addresses are nearby this person. _
|